Federal Trade Commission December 13, 2016 – Federal Register Recent Federal Regulation Documents

Granting of Request for Early Termination of the Waiting Period Under the Premerger Notification Rules
Document Number: 2016-29771
Type: Notice
Date: 2016-12-13
Agency: Federal Trade Commission, Agencies and Commissions
Enforcement Policy Statement on Marketing Claims for OTC Homeopathic Drugs
Document Number: 2016-29770
Type: Notice
Date: 2016-12-13
Agency: Federal Trade Commission, Agencies and Commissions
The Federal Trade Commission has issued an Enforcement Policy Statement on Marketing Claims for OTC Homeopathic Drugs. The Statement describes the level of substantiation that the Commission expects for marketing claims for over-the-counter (OTC) homeopathic drugs. It also recognizes that marketing claims for OTC homeopathic products for an unsubstantiated indication might be made non-deceptive by the inclusion of additional explanatory information that effectively communicates to consumers that there is no scientific evidence that the product works and that the product's claims are based only on theories of homeopathy from the 1700s that are not accepted by most modern medical experts.